About Mycelial
Mycelial is a private company based in New York, New York, incorporated in 2021 in Delaware. It has reported $395,000 raised in three offerings on Form D since June 2021. Its chief executive is Michael Tanenbaum.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 30, 2023 | Jun 13, 2023 | $270,000of $3.0M target | 7 | $38,571 | OptionsRule 506(b) | Form D ↗ |
| Nov 3, 2022 | Nov 4, 2022 | $25,000of $1.0M target | 1 | $25,000 | OptionsRule 506(b) | Form D ↗ |
| May 21, 2021 | Jun 4, 2021 | $100,000of $2.5M target | 3 | $33,333 | Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, three offerings | $395,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Mycelial's Form D filed Jun 13, 2023.
MT
Michael Tanenbaum
Chief Executive Officer and director
AL
Aneel Lakhani
Director
Earlier filings also listed Gerred Dillon (executive officer and director, last listed Nov 2022).